Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial-Reference-Cited by-同舟云学术

Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial

Published:2021-06 Issue:6 Volume:3 Page:e410-e418
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Cremer Paul C,Abbate Antonio,Hudock Kristin,McWilliams Carla,Mehta Jinesh,Chang Steven Y,Sheng Calvin C,Van Tassell Benjamin,Bonaventura Aldo,Vecchié Alessandra,Carey Brenna,Wang Qiuqing,Wolski Katherine E,Rajendram Prabalini,Duggal Abhijit,Wang Tisha S,Paolini John F,Trapnell Bruce C,Gladish Deborah,Myers Karen,Kuramochi Yuki,Sewell Christina,Balog Craig,Kosty Sweeny Denise,Kandrac Jill,Spencer Stephanie,Goyanes Alice,Sahoo Debasis,Dugar Siddharth,Aguillon Prada Robier,Nichols Dave,Celiberti Jeannie,Partisano Annie,Fang Fang,Coehlo Jennifer,Perrin Randy,Mandell Brian,Gordon Steven,Wiedemann Herbert,Young James,Greer Joan,Ho Ai-Chen,Ladd Any,Mihalick Virginia,Montpetit Alison,O'Brine Joyce,Owen Catherine,Pal Mary,Priday Anna,Raj Sedhai Yub,Wohlford George,Hummel Nicole,Korbee Leslie

Funder

Kiniksa Pharmaceuticals Corp

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference28 articles.

1. Remdesivir for the treatment of COVID-19—final report;Beigel;N Engl J Med,2020

2. Dexamethasone in hospitalized patients with COVID-19;Horby;N Engl J Med,2021

3. Baricitinib plus remdesivir for hospitalized adults with COVID-19;Kalil;N Engl J Med,2021

4. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet,2020

5. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review;Wiersinga;JAMA,2020

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Steroids and Immunomodulatory Therapies for Acute Respiratory Distress Syndrome;Clinics in Chest Medicine;2024-09

2. GMCSF: More an Inflammatory Immune ‘Cytokine’ Than a Growth Factor;Indian Journal of Rheumatology;2024-06-23

3. Making Drug Approval Decisions in the Face of Uncertainty: Cumulative Evidence versus Value of Information;Medical Decision Making;2024-06-03

4. Adverse drug reactions associated with COVID-19 management;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-05-14

5. COVID-19 Pneumonia and Cytokine Storm Syndrome;Advances in Experimental Medicine and Biology;2024